Form 4: Precipio Director Acquires Shares as Q3-25 Compensation

Precipio, Inc. Director Ronald Asbury Andrews acquired 568 shares of common stock at $17.58 per share as compensation for Q3-25 board service.

Summary

• Ronald Asbury Andrews, a Director of Precipio, Inc. (PRPO), acquired 568 shares of common stock.
• The transaction occurred on October 15, 2025, with shares priced at $17.58 each.
• These shares were granted as compensation for his service as a member of the Board of Directors for Q3-25, in lieu of a cash payment.
• Following this transaction, Mr. Andrews beneficially owns a total of 15,708 shares of Precipio, Inc. common stock directly.

Sentiment

Score: 7

Explanation: The filing reports a routine transaction where a director received stock as compensation. This is generally viewed as a positive for aligning interests but is not a significant event to dramatically alter sentiment.

Positives

• Director Ronald Asbury Andrews increased his direct beneficial ownership in Precipio, Inc. by 568 shares.
• The decision to accept stock in lieu of cash for Q3-25 board compensation demonstrates alignment of the director's interests with those of the company's shareholders.

Negatives

• No negative information is disclosed in this routine Form 4 filing.

Risks

• This Form 4 filing does not contain information regarding specific risks.

Future Outlook

This Form 4 filing does not provide any forward-looking statements or guidance.

Management Comments

• 568 shares of common stock were granted upon the close of business on October 15, 2025, as a consideration in lieu of cash payment of compensation for service as a member of the Board of Directors for Q3-25.

Industry Context

Compensating board members with equity, either fully or partially, is a common practice across various industries. This approach is often favored as it aligns the interests of directors with those of shareholders, encouraging long-term value creation.

Comparison to Industry Standards

• The practice of granting stock as compensation for board service is a widely accepted corporate governance standard, aligning director incentives with shareholder value.
• Many public companies, including those in the biotechnology and diagnostics sector like Precipio, utilize equity compensation for their non-employee directors. For example, similar practices are observed at companies such as Guardant Health (GH) or Exact Sciences (EXAS), where directors often receive a mix of cash and equity for their service, reflecting a commitment to long-term performance.

Related Party Transactions

• The transaction involves a director receiving compensation from the company in the form of stock, which is a common type of related party transaction.

Stakeholder Impact

• **Shareholders:** The acquisition of shares by a director, particularly as compensation, can be viewed positively as it increases insider ownership, potentially signaling confidence in the company's future and aligning management's interests with shareholder returns.
• **Management/Board:** The use of stock as compensation helps conserve cash, which can be beneficial for the company's liquidity and operational flexibility.

Next Steps

• No specific future actions, events, or milestones are mentioned in this Form 4 filing.

Key Dates

Recommendation

This Form 4 reports a routine stock grant to a director as compensation, which is a common practice and does not provide sufficient new information to alter an investment thesis. It indicates alignment of interests but is not a significant catalyst for a 'buy' or 'sell' recommendation.

Keywords

Precipio, PRPO, Form 4, Insider Trading, Director Compensation, Stock Grant, Equity Acquisition, Ronald Andrews